Patient presents with signs and symptoms consistent with Methicillin-Susceptible Staphylococcus Aureus (MSSA) infection.  Clinical findings include [localized or systemic infection descriptor, e.g., cellulitis of the left lower extremity,  pneumonia, bacteremia].  Area of infection exhibits [description of affected area, e.g., erythema, edema, warmth, purulent drainage, induration]. Patient reports [associated symptoms, e.g., pain, fever, chills, malaise].  Differential diagnosis includes [list relevant differential diagnoses, e.g.,  streptococcal infection, other bacterial infections, abscess].  Laboratory results show [mention specific lab tests and results, e.g., positive wound culture for MSSA, elevated white blood cell count, leukocytosis].  Based on the clinical presentation, laboratory findings, and diagnostic criteria, the diagnosis of MSSA infection is confirmed. Treatment plan includes [specific antibiotics, e.g., Cefazolin, Dicloxacillin,  Nafcillin] administered [route of administration, e.g., intravenously, orally] for [duration] along with [supportive measures, e.g., wound care, pain management, incision and drainage].  Patient education provided regarding medication adherence, infection control measures, and potential complications. Follow-up scheduled in [timeframe] to assess treatment response and monitor for any signs of clinical deterioration or treatment failure.  ICD-10 code [appropriate ICD-10 code based on infection site and type] and CPT codes [relevant CPT codes for procedures performed, e.g., incision and drainage, wound debridement] will be documented for billing and coding purposes.